Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News eXoZymes Inc EXOZ

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia... see more

Opinion & Analysis (NDAQ:EXOZ)

No current opinion is available.

Bullboard Posts (NDAQ:EXOZ)

RE:eX

Here is an accompanying video where I spoke the company's CEO, Michael Heltzen. INTERVIEW VIDEO
portiss - May 13, 2025

eX

Thrilled to finally share my extensive report on eXoZymes Inc!   SLACK CAPITAL REPORT The company has developed an...
portiss - May 13, 2025

Company Report on ExoZymes

Company Report on ExoZymes Inc will be coming out in the next few weeks https://www.slack-capital.com/
SlackCapital - February 23, 2025

Investment Report

Recently been diving deep into eXoZymes Inc.  Have an investment report coming out soon which will be released in a months time...
SlackCapital - February 14, 2025

RE:New to Invizyne

Hey mate, doesn't seem to be any around. Welcome to message me on X about Invizyne @slack_capital
SlackCapital - February 7, 2025

New to Invizyne

Looking at Invizyne stock for the first time... Are there any active forums/discussions about the stock's potential?
cybernet - November 21, 2024